Monitoring Early Breast Cancer Response To Neoadjuvant Therapy Using H-Scan Ultrasound Imaging: Preliminary Preclinical Results




Journal Title

Journal ISSN

Volume Title


John Wiley and Sons Ltd.


Objective—H-scan imaging is a new ultrasound technique used to visualize the relative size of acoustic scatterers. The purpose of this study was to evaluate the use of H-scan ultrasound imaging for monitoring early tumor response to neoadjuvant treatment using a preclinical breast cancer animal model. Methods—Real-time H-scan ultrasound imaging was implemented on a programmable ultrasound scanner (Vantage 256; Verasonics Inc., Kirkland, WA) equipped with an L11-4v transducer. Bioluminescence and H-scan ultrasound was used to image luciferase-positive breast cancer–bearing mice at baseline and at 24, 48, and 168 hours after administration of a single dose of neoadjuvant (paclitaxel) or sham treatment. Animals were euthanized at 48 or 168 hours, and tumors underwent histologic processing to identify cancer cell proliferation and apoptosis. Results—Baseline H-scan ultrasound images of control and therapy group tumors were comparable, but the latter exhibited significant changes over the 7-day study (P 0.40, P < .04). Conclusion—Preliminary preclinical results suggest that H-scan ultrasound imaging is a new and promising tissue characterization modality. H-scan ultrasound imaging may provide prognostic value when monitoring early tumor response to neoadjuvant treatment. © 2018 by the American Institute of Ultrasound in Medicine.


Due to copyright restrictions and/or publisher's policy full text access from Treasures at UT Dallas is not available. UTD affiliates may be able to acquire a copy by using the link below to contact university Interlibrary Loan.


Apoptosis, Cancer, Diagnostic ultrasonic imaging, Neoadjuvant Therapy, Cell Death, Cell Proliferation, Mammals, Tumors, Breast--Cancer


©2018 American Institute of Ultrasound in Medicine